General information, not legal advice. Everything below describes how research reagents are supplied and regulated in general terms. It is not advice on your particular situation. For that, speak to a qualified Irish solicitor or to the HPRA directly.
Peptides are not one legal category. The laboratory offers here are not authorised finished medicines, but their research-use label does not decide classification. The actual product, its presentation and function matter, along with the recipient and supply route.
The distinction that actually matters
People usually ask whether a compound is "legal" as though substances fall into two boxes, banned and allowed. For research peptides the meaningful question is different: what is it being supplied as?
A medicine may be defined by presentation or by pharmacological, immunological or metabolic action. The applicable authorisation or exemption concerns the actual product and supply route. A laboratory label and absence of dosing instructions do not by themselves place a product outside medicines law.
Presentation, function and the intended supply all need to be considered. Dosing instructions or treatment claims can affect presentation; removing them or adding a COA does not automatically decide the status of the same vial.
Which regulator applies
The Health Products Regulatory Authority (HPRA) regulates medicines, including product classification and enforcement concerning unauthorised products. Its definition guide explains why presentation and function both matter. Laboratory wording does not create an automatic exemption.
Where specific compounds stand
- BPC-157 - the laboratory offer is not an authorised finished medicine; its name alone does not determine classification or import requirements.
- GHK-Cu - a copper tripeptide used in laboratory and cosmetic-science research. A laboratory material is distinct from a finished cosmetic or medicine.
- TB-500 - the trade name alone does not identify every supplied material or establish a common legal status.
- Retatrutide (LY3437943) - investigational, without EU marketing authorisation as a finished medicine. Clinical-trial supply and laboratory offers are different contexts.
- Semaglutide - authorised finished prescription medicines contain this substance; their approvals and supply rules do not extend to every laboratory offer under the same name.
How research buyers in Ireland receive orders
Ordinary Union goods in free circulation, sent within the EU customs territory, normally avoid third-country import clearance and import duty. A supplier's EU address alone does not confirm the goods' status; product restrictions and checks remain separate. Recent deliveries to Ireland have taken 10 days or longer. The selected supplier and carrier can confirm the current estimate.
What to check before ordering
Start with the available certificate of analysis: check the laboratory, tested sample or batch identifier, methods and results, then the connection to the offered material and received vial. A sample result without that connection is not evidence for every vial. Our available documents are on the lab reports page and how to read a COA explains the checks.
Research-use wording should describe the intended purpose clearly. It does not itself determine the legal category; assess the actual offer rather than relying on a disclaimer or an implied treatment claim.
Frequently asked questions
Are peptides legal in Ireland?
Peptides are not one legal category. Laboratory offers are not authorised finished medicines, but a research-use label alone does not decide classification. HPRA considers the actual product, its presentation and pharmacological, immunological or metabolic action. The compound name alone does not establish whether a purchase or import is permitted.
Is BPC-157 legal in Ireland?
The BPC-157 laboratory offer on this site is not an authorised finished medicine. Its name or research-use label does not establish permission to buy or import a particular product; classification, recipient and supply requirements must be assessed for the actual offer.
Is GHK-Cu legal in Ireland?
GHK-Cu is a copper tripeptide studied in laboratory and cosmetic-science research. A laboratory material and a finished cosmetic or medicine are different products. The ingredient name does not determine the classification or permitted supply of every formulation.
Is Retatrutide legal in Ireland?
Retatrutide remains investigational and has no marketing authorisation as a finished medicine in Ireland or the EU. Clinical-trial supply is distinct from a laboratory offer. Authorised finished medicines containing semaglutide have their own prescription and supply rules; those approvals do not cover laboratory materials with the same substance name.
How do you get research peptides in Ireland?
Ordinary Union goods in free circulation, sent within the EU customs territory, normally avoid third-country import clearance and import duty. Product restrictions and checks remain separate. Recent deliveries to Ireland have taken 10 days or longer; check the selected supplier and carrier for the current estimate.
What should you check before buying?
Check the laboratory, methods, results and sample or batch identifier on the available report, then its connection to the offered material and the received vial. A tested sample result does not establish every vial or batch. Research-use wording describes the intended purpose; it does not replace product classification.
Related pages
Peptides Ireland
The main Ireland page: catalogue, purity documentation and delivery times.
What are peptides?
Start here for the basic terminology before the regulatory detail.
Lab reports
The actual certificates of analysis, so you can check a batch number rather than take a claim on trust.
How to read a COA
What a genuine certificate contains, and which omissions should make you walk away.
All products referenced are supplied strictly for laboratory research and are not for human or veterinary use. Nothing here is medical or legal advice. See the full disclaimer.